Zyban (bupropion hydrochloride) is currently unavailable in Australia, with supply predicted to be impacted until March 2020.
To obtain alternative unapproved products, psychiatrists can apply to the Therapeutic Goods Administration (TGA) via the Special Access Scheme (Category B).
The College has been notified that the following suppliers have sourced alternative products. For more information on how to order this alternative supply, please contact them directly.
||Tel: 1300 012 686
||Tel: 1300 788 261
The application form can be found on the Special Access Scheme page of the TGA website.
For more information and to subscribe to updates, see the TGA’s Medicine Shortages Information Initiative.